Evidence map›Paper›PMID 28106483›Full record

ArticleJournal of the Royal Society of Medicine2017

Evaluating Cinchona bark and quinine for treating and preventing malaria.

G Gachelin, P Garner, E Ferroni, U Tröhler, I Chalmers

Open access · bronzeAbstract readHistorical Article
In one paragraph

Article in Journal of the Royal Society of Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Article
  3. Chemical Complexity of Food and Implications for Therapeutics.The New England journal of medicine · 2025
    Review
  4. Article
  5. Review
  6. Beyond Glucose: The Dual Assault of Oxidative and ER Stress in Diabetic Disorders.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Review
  7. Article
  8. Novel Therapeutics for Malaria.Pharmaceutics · 2023
    Review
  9. Review
  10. Article
  11. Molecules (Basel, Switzerland) · 2022
    Review
  12. Review
  13. Article
  14. Probing the chemical constituents ofRoyal Society open science · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review.Clinical pharmacology : advances and applications · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

G GachelinLaboratoire SPHere, UMR 7219, CNRS-Université Paris 7, 75205 Paris, Cedex 13, France.
P GarnerLaboratoire SPHere, UMR 7219, CNRS-Université Paris 7, 75205 Paris, Cedex 13, France.
E FerroniLaboratoire SPHere, UMR 7219, CNRS-Université Paris 7, 75205 Paris, Cedex 13, France.
U TröhlerLaboratoire SPHere, UMR 7219, CNRS-Université Paris 7, 75205 Paris, Cedex 13, France.
I ChalmersLaboratoire SPHere, UMR 7219, CNRS-Université Paris 7, 75205 Paris, Cedex 13, France.
methodS in Patient-centered outcomes and HEalth ResEarchCentre National de la Recherche Scientifique · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CinchonaHistory, 17th CenturyHistory, 18th CenturyHistory, 19th CenturyHistory, 20th CenturyHumansMalariaPlant BarkQuinineQuinine

Identifiers

PMID28106483
PMCPMC5298425
OpenAlexW2754936959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.